Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)‘s stock had its “outperform” rating restated by research analysts at JMP Securities in a research note issued to investors on Wednesday, The Fly reports. A number of other equities analysts have also issued reports on the company. Stifel Nicolaus increased their price objective on Vertex Pharmaceuticals from $100.00 to $129.00 and […]
